KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation

Am J Transplant. 2011 Sep;11(9):1959-64. doi: 10.1111/j.1600-6143.2011.03621.x. Epub 2011 Jun 30.

Abstract

Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system with the ability to detect HLA class I disparities via killer-cell immunoglobulin-like receptors (KIR). To test whether such KIR-ligand mismatches contribute to the rejection of human solid allografts, we did a retrospective cohort study of 397 HLA-DR-compatible kidney transplantations and determined the KIR and HLA genotypes of recipients and the HLA genotypes of donors. In transplantations compatible for HLA-A, HLA-B and HLA-DR (n = 137), in which a role for T cells and HLA antibodies in rejection was minimized, KIR-ligand mismatches were associated with an approximately 25% reduction in 10-year death-censored graft survival (p = 0.043). This effect was comparable to the effect of classical HLA-A and HLA-B incompatibility, and in HLA-A,-B-incompatible transplantations (n = 260) no significant additional effect of KIR-ligand mismatches was observed. Multivariate Cox regression analysis confirmed the effect of KIR-ligand mismatching as an independent risk factor in HLA-A,-B,-DR-compatible transplantations (hazard ratio 2.29, range 1.03-5.10, p = 0.043). This finding constitutes the first indication that alloreactive NK cells may thwart the success of HLA-compatible kidney transplantations, and suggests that suppression of NK-cell activity can improve the survival of such kidney grafts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Graft Survival*
  • Histocompatibility Testing*
  • Humans
  • Kidney Transplantation*
  • Ligands
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Receptors, KIR / metabolism*
  • Retrospective Studies

Substances

  • Ligands
  • Receptors, KIR